Introduction Lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI), is a cornerstone in the treatment of HIV/AIDS and chronic hepatitis B. Since its introduction in the mid-1990s, lamivudine has played a critical role in antiretroviral therapy (ART), helping millions manage their conditions and live healthier lives. The success of lamivudine is not just a testament to its therapeutic efficacy but also to the commitment to quality and innovation demonstrated by its manufacturers. This article explores the manufacturing landscape of lamivudine, emphasizing the industry’s dedication to producing high-quality, innovative, and accessible treatments. The Role of Lamivudine in Modern Medicine HIV/AIDS Treatment Lamivudine…
Read More